Location History:
- Congresbury, GB (1996)
- Bristol, GB (1996 - 1997)
Company Filing History:
Years Active: 1996-1997
Title: Belinda Mary Kumpel: Innovator in Monoclonal Antibodies
Introduction
Belinda Mary Kumpel is a distinguished inventor based in Bristol, GB. She has made significant contributions to the field of immunology, particularly in the development of human monoclonal antibodies. With a total of 4 patents to her name, her work has had a profound impact on medical science.
Latest Patents
Kumpel's latest patents include groundbreaking inventions related to human anti-Rh(D) monoclonal antibodies. The first patent describes human monoclonal antibodies that bind to the Rh(D) antigen while not interacting with other antigens of the Rh blood group system. These antibodies are characterized as IgG1 proteins with kappa light chains and are designed for Rh-typing of red blood cells and passive immunization to prevent hemolytic disease of the newborn. The second patent similarly outlines human monoclonal antibodies that are IgG3 proteins and bind to the same antigens, further emphasizing their utility in medical applications.
Career Highlights
Belinda Kumpel is currently associated with the National Blood Authority, where she continues her research and development efforts. Her work has been pivotal in advancing the understanding and application of monoclonal antibodies in clinical settings.
Collaborations
Kumpel has collaborated with notable colleagues, including Alan Doyle and Benjamin Arthur De Burgh Bradley, contributing to a rich environment of innovation and research.
Conclusion
Belinda Mary Kumpel's contributions to the field of immunology through her patents on monoclonal antibodies highlight her role as a leading inventor. Her work not only advances scientific knowledge but also has practical implications for healthcare.